Promakhos Therapeutics

A therapeutics platform for curing inflammatory disorders

Boston, United States · Founded 2021 · $669K raised

Employees
1–10
Founded
2021
Total Funding
$669K
Last Round
$272K GrantSep 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.

Summary

Promakhos Therapeutics is a Healthcare company based in Boston, United States, founded in 2021. It has raised $669K in total across 3 rounds, most recently a $272K Grant round in Sep 2023. Investors include HHS, Asymmetry Ventures and Pioneer Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase I (NIH)Sep 2023
$272K

Sign up to see all 3 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Promakhos Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/promakhos-therapeutics"><img src="https://indexed.vc/api/badge/company/promakhos-therapeutics" alt="Promakhos Therapeutics on Indexed.vc" width="260" height="76" /></a>